Regulation of the protein stability of POSH and MLK family.
10.1007/s13238-010-0111-1
- Author:
Chunyan WANG
1
;
Yang TAO
;
Yaqing WANG
;
Zhiheng XU
Author Information
1. Key Laboratory of Molecular and Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China.
- Publication Type:Journal Article
- MeSH:
Adaptor Proteins, Signal Transducing;
genetics;
metabolism;
Animals;
Apoptosis;
physiology;
Base Sequence;
Cell Line;
DNA Primers;
genetics;
Humans;
JNK Mitogen-Activated Protein Kinases;
antagonists & inhibitors;
genetics;
metabolism;
MAP Kinase Kinase Kinases;
genetics;
metabolism;
Mutant Proteins;
genetics;
metabolism;
Nuclear Proteins;
genetics;
metabolism;
PC12 Cells;
Peptide Fragments;
genetics;
metabolism;
Protein Stability;
Rats;
Recombinant Proteins;
genetics;
metabolism;
Signal Transduction;
physiology;
Transfection;
Ubiquitin-Protein Ligases;
genetics;
metabolism
- From:
Protein & Cell
2010;1(9):871-878
- CountryChina
- Language:English
-
Abstract:
Sequential activation of the JNK pathway components, including Rac1/Cdc42, MLKs (mixed-lineage kinases), MKK4/7 and JNKs, plays a required role in many cell death paradigms. Those components are organized by a scaffold protein, POSH (Plenty of SH3's), to ensure the effective activation of the JNK pathway and cell death upon apoptotic stimuli. We have shown recently that the expression of POSH and MLK family proteins are regulated through protein stability. By generating a variety of mutants, we provide evidence here that the Nterminal half of POSH is accountable for its stability regulation and its over-expression-induced cell death. In addition, POSH's ability to induce apoptosis is correlated with its stability as well as its MLK binding ability. MLK family's stability, like that of POSH, requires activation of JNKs. However, we were surprised to find out that the widely used dominant negative (d/n) form of c-Jun could down-regulate MLK's stability, indicating that peptide from d/n c-Jun can be potentially developed into a therapeutical drug.
